Showing results (21-30 of 65) with videos related to
Sort By:
Pageof 7
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 8, 2006
Low molecular weight advanced glycation end products predict mortality in asymptomatic patients receiving chronic haemodialysisMatthew A Roberts, Merlin C Thomas, Dharsh Fernando, et al.Journal of the American Society of Nephrology : JASN|July 7, 2018
Phosphorylation of Acetyl-CoA Carboxylase by AMPK Reduces Renal Fibrosis and Is Essential for the Anti-Fibrotic Effect of MetforminMardiana Lee, Marina Katerelos, Kurt Gleich, et al.Progress in Cardiovascular Diseases|June 26, 2024
Calcified coronary lesions: Imaging, prognosis, preparation and treatment state of the art reviewDavid A Power, Rayyan Hemetsberger, Serdar Farhan, et al.American Journal of Physiology. Renal Physiology|November 13, 2004
Regulation of the energy sensor AMP-activated protein kinase in the kidney by dietary salt intake and osmolalityScott Fraser, Peter Mount, Rebecca Hill, et al.FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|December 13, 2025
Obesity Augments Necroinflammation and Worsens Injury With Folic Acid-Induced Acute Kidney InjuryMarina Katerelos, Chathri Ratnayake, Kurt Gleich, et al.International Journal of Experimental Pathology|April 27, 2019
Absence of the β1 subunit of AMP-activated protein kinase reduces myofibroblast infiltration of the kidneys in early diabetesSuet-Wan Choy, Scott A Fraser, Marina Katerelos, et al.American Journal of Physiology. Renal Physiology|May 26, 2005
Acute renal ischemia rapidly activates the energy sensor AMPK but does not increase phosphorylation of eNOS-Ser1177Peter F Mount, Rebecca E Hill, Scott A Fraser, et al.Atherosclerosis|January 15, 2008
Bradykinin stimulates endothelial cell fatty acid oxidation by CaMKK-dependent activation of AMPKPeter F Mount, Natalie Lane, Sudharsan Venkatesan, et al.Kidney International|April 23, 2002
Renal ischemia-reperfusion increases endothelial VEGFR-2 without increasing VEGF or VEGFR-1 expressionJohn Kanellis, Kathy Paizis, Alison J Cox, et al.Kidney International|August 2, 2013
AMG 416 (velcalcetide) is a novel peptide for the treatment of secondary hyperparathyroidism in a single-dose study in hemodialysis patientsKevin J Martin, Karen Pickthorn, Saling Huang, et al.Pageof 7